HLB Pept CEO Kyungjae Shim Purchases Additional Treasury Shares: "Commitment to Responsible Management and Enhancing Corporate Value"

HLB Pept, a company specializing in peptide materials, announced in a disclosure on May 20 that CEO Kyungjae Shim had purchased 2,170 shares of the company's stock on the open market.

With this purchase, CEO Shim's total shareholding increased to 22,470 shares. The company explained that this purchase was made based on confidence in the company's growth potential and its long-term corporate value.

Since his appointment as CEO in March last year, Shim has consistently purchased treasury shares, demonstrating his commitment to responsible management. In the market, this additional purchase is also interpreted as an effort to enhance shareholder value and strengthen management accountability.

Since the beginning of this year, HLB Pept has been accelerating both its efforts to strengthen its peptide contract development and manufacturing (CDMO) business and to expand into new business areas. Recently, the company launched the "Labcen Peptide Calming Serum," targeting the improvement of inflammatory skin conditions such as acne, and has received a positive response in the market.

In addition, the company is actively pursuing high-difficulty peptide substance development projects in collaboration with domestic and international pharmaceutical companies. Leveraging its peptide material technology, HLB Pept is expanding its business scope not only in the medical and bio sectors but also into cosmetics.

An HLB Pept official stated, "CEO Kyungjae Shim has consistently emphasized the enhancement of shareholder value and responsible management," adding, "This treasury share purchase is also a meaningful decision that demonstrates his commitment to responsible management regarding the company's growth and enhancement of corporate value."

Shim's continued purchase of treasury shares is regarded as a signal of the management's confidence in HLB Pept's growth strategy and expansion of the peptide business.

This content was produced with the assistance of AI translation services.